N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

Building Cognitive Resilience to Vaccine Misinformation Using AI in Europe

Sponsor: London School of Hygiene and Tropical Medicine • ClinicalTrials.gov ID: NCT07551986

Registry updated: 2026-09-29
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

This multi-country trial evaluates an AI chatbot designed to counter cognitive biases and inoculate parents against vaccine misinformation, embedded within a large survey across five European countries (n=5,000). Scaled from a 2026 single-country study, outcomes compare behavioural and attitudinal responses against standard-of-care materials (e.g., UNICEF infographics) to identify effective, scalable misinformation interventions.

Interventions

  • AI-driven chatbot (Behavioral)
    A tailored AI-driven chatbot designed to counter vaccine misinformation.
  • Social media infographic (Behavioral)
    A UNICEF social media infographic with three "myth vs. fact" statements on vaccination.

Eligibility criteria

Inclusion Criteria: * Parents or caregivers with children under 18 years old in the five target countries (UK, Netherlands, Croatia, Latvia, and Slovakia); and * Those who have regular access to a digital device and the internet Exclusion Criteria: * Participants who do not meet the inclusion criteria.

Conditions

Healthy

Locations

  • London School of Hygiene and Tropical Medicine — London, United Kingdom
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record